Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer

Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer

Abstract Background Lung cancer is a leading cause of morbidity and mortality globally. Despite advances in targeted and immunotherapies, overall survival (OS) rates remain suboptimal. Cyclin-A2 (CCNA2), known for its upregulation in various tumors and role in tumorigenesis, has an undefined functio...

Full description

Bibliographic Details
Main Authors: Liming Zhang, Shaoqiang Wang, Lina Wang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Pulmonary Medicine
Subjects:
Cyclin-A2 (CCNA2)
Non-small cell lung cancer (NSCLC)
Prognosis
Diagnosis
Immune infiltration
Bioinformatics analysis
Online Access:https://doi.org/10.1186/s12890-025-03490-7

Internet

https://doi.org/10.1186/s12890-025-03490-7

Similar Items